Wang Zengsi, Zhang Yanmin, Xiong Fei, Li Hongbo, Ding Yanqiong, Gao Yihua, Zhao Li, Wan Sheng
Department of nephrology, Wuhan No.1 hospital, 430022, Wuhan, Hubei Province, China.
BMC Nephrol. 2015 Mar 21;16:33. doi: 10.1186/s12882-015-0023-7.
Socioeconomic characteristics may affect the outcomes of patients treated with peritoneal dialysis (PD). There are two major medical insurances in China: the New Cooperative Medical Scheme (NCMS), mainly for rural residents, and the Urban Employees' Medical Insurance (UEMI). The aim of the present study was to assess the effect of medical insurance type on survival of patient undergoing PD.
This was a prospective study in adult patients who underwent PD at the Wuhan No.1 Hospital between January 2008 and December 2013. Patients had received continuous ambulatory PD for >3 months. Patients were divided according to their medical insurance. Demographic and socioeconomic data, biochemical parameters and primary clinical outcomes including all-cause mortality, switch to hemodialysis and kidney transplantation were analyzed.
There were 415 patients with UEMI and 149 with NCMS. Compared with UEMI, patients with NCMS were younger, and had shorter dialysis duration, smaller proportion of diabetic nephropathy, more severe anemia, and more frequent hyperphosphatemia and hyperuricemia. Total Kt/V, creatinine clearance and residual renal function were not different. There was no difference in technique survival (P > 0.05) between the two groups, but rural patients showed lower overall survival (P < 0.05). Multivariate analysis showed that NCMS was independently associated with lower survival (RR = 1.49; 95% CI = 1.04-2.15).
Medical insurance model is independently associated with PD patient survival.
社会经济特征可能会影响接受腹膜透析(PD)治疗患者的预后。中国有两种主要医疗保险:新型农村合作医疗制度(新农合),主要覆盖农村居民;以及城镇职工医疗保险(UEMI)。本研究旨在评估医疗保险类型对接受PD治疗患者生存情况的影响。
这是一项针对2008年1月至2013年12月期间在武汉市第一医院接受PD治疗的成年患者的前瞻性研究。患者接受持续非卧床腹膜透析超过3个月。根据医疗保险类型对患者进行分组。分析人口统计学和社会经济数据、生化参数以及包括全因死亡率、转为血液透析和肾移植在内的主要临床结局。
有415例患者参加城镇职工医疗保险,149例参加新农合。与参加城镇职工医疗保险的患者相比,参加新农合的患者更年轻,透析时间更短,糖尿病肾病比例更低,贫血更严重,高磷血症和高尿酸血症更频繁。总Kt/V、肌酐清除率和残余肾功能无差异。两组间技术生存率无差异(P>0.05),但农村患者的总生存率较低(P<0.05)。多因素分析显示,新农合与较低的生存率独立相关(RR = 1.49;95%CI = 1.04 - 2.15)。
医疗保险模式与腹膜透析患者的生存情况独立相关。